PRELUDE CAPITAL MANAGEMENT, LLC - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 186 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$149,024
-13.0%
15,395
-1.5%
0.01%0.0%
Q1 2023$171,217
-24.9%
15,622
+51.7%
0.01%
+66.7%
Q3 2021$228,000
+1325.0%
10,300
+836.4%
0.01%
+500.0%
Q3 2020$16,000
+23.1%
1,100
+37.5%
0.00%0.0%
Q2 2020$13,000
-87.1%
800
-84.0%
0.00%
-75.0%
Q4 2019$101,0005,0000.00%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 503,248$6,535,00010.30%
Prosight Management, LP 360,834$4,685,0003.84%
Healthcare Value Capital, LLC 100,000$1,299,0002.89%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,748,208$22,700,0002.32%
DG Capital Management, LLC 591,154$7,676,0001.83%
NEA Management Company, LLC 5,172,683$67,193,0001.51%
Altium Capital Management LP 408,908$5,310,0001.47%
IRONWOOD INVESTMENT MANAGEMENT LLC 170,316$2,212,0001.17%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 298,500$3,875,0001.02%
KNOTT DAVID M 154,840$2,011,0000.86%
View complete list of AURINIA PHARMACEUTICALS INC shareholders